UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000012849
Receipt number R000015013
Scientific Title Examination of utility of fulvestrant 500mg intended for climacteric junior line relapse breast cancer patient
Date of disclosure of the study information 2014/01/29
Last modified on 2016/02/14 22:33:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Examination of utility of fulvestrant 500mg intended for climacteric junior line relapse breast cancer patient

Acronym

NGFBCS14-01

Scientific Title

Examination of utility of fulvestrant 500mg intended for climacteric junior line relapse breast cancer patient

Scientific Title:Acronym

NGFBCS14-01

Region

Japan


Condition

Condition

ER-positive postmenopausal metastatic/inoperable breast cancer

Classification by specialty

Breast surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy and safety of 500mg Fulvestrant therapy in patients with inoperable or metastatic ER-positibe postmenopausal breast cancer within 2-4 ET regimens.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Clinical Benefit Rate(CBR)

Key secondary outcomes

Overall Response Rate(ORR)
Progression Free Survival (PFS)
Safety


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

1. Patients who were histologically or cytologically diagnosed as inoperable/metastatic breast cancer.
2. ER-positibe in primary or metastatic lesions.
3.Patient of either of 1 for which endocrinotherapy is needed due to progress
relapse breast cancer as follows) -4).
1)Patient who relapsed within 12 months in supplementary treatment period of after the operation by endocrinotherapy or after supplementary treatment ends after the operation.
2)Patient where it relapses after 12 months or more have passed since supplementary treatment ended by endocrinotherapy after the operation, and progress was admitted for endocrinotherapy period afterwards.
3)Patient where progress was admitted for endocrinotherapy period as the first treatment to progress breast cancer patient.
4)Patient from whom progress was admitted in the 2nd or the third endocrinotherapy to progress/recurrence breast cancer
4. The 17th edition (June, 2012)/of the breast cancer handling rule Target (It is possible to measure it) change to a morbid state by the
RECIST standard (the 1.1th edition) is possessed.
5.Age 45-year-old or more postmenopausal women.
6. Written informed consent

Key exclusion criteria

1. Life threatening including
2.Inflammatory breast cancer
3. Allergy to fulvestrant.
4. Previous therapy by fulvestrant
5. Patients considered ineligible by the attending physician.

Target sample size

48


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Junichi Tobinaga

Organization

JA Aichi Konan Kosei Hospital

Division name

Breast surgery

Zip code


Address

137 Omatsubara Takaya-cho Konan City Aichi Japan

TEL

0587-51-3333

Email

j-tobinaga@konan.jaaikosei.or.jp


Public contact

Name of contact person

1st name
Middle name
Last name Junichi Tobinaga

Organization

JA Aichi Konan Kosei Hospital

Division name

Breast surgery

Zip code


Address

137 Omatsubara Takaya-cho Konan City Aichi Japan

TEL

0587-51-3333

Homepage URL


Email

j-tobinaga@konan.jaaikosei.or.jp


Sponsor or person

Institute

JA Aichi Konan Kosei Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

JA愛知厚生連 江南厚生病院      JA Aichi Konan Kosei Hospital


Other administrative information

Date of disclosure of the study information

2014 Year 01 Month 29 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2013 Year 11 Month 12 Day

Date of IRB


Anticipated trial start date

2014 Year 01 Month 01 Day

Last follow-up date

2017 Year 09 Month 30 Day

Date of closure to data entry

2018 Year 04 Month 01 Day

Date trial data considered complete

2018 Year 05 Month 01 Day

Date analysis concluded

2018 Year 06 Month 01 Day


Other

Other related information

None


Management information

Registered date

2014 Year 01 Month 14 Day

Last modified on

2016 Year 02 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015013


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name